Current evidence for first-line advanced therapies in pediatric ulcerative colitis: a critical review. (PubMed, Inflamm Bowel Dis) - Oct 10, 2026 - "Current pediatric evidence supports the efficacy of multiple advanced therapies and has characterized important safety outcomes; however, evidence establishing therapeutic efficacy should be distinguished from evidence directly informing first-line treatment selection. Future pediatric research should increasingly generate comparative and predictive evidence that informs which effective advanced therapy should be selected first and for whom."
Journal • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Oncology • Pediatrics • Ulcerative Colitis • IL23A
|